Search

Your search keyword '"Feiterna-Sperling C"' showing total 128 results

Search Constraints

Start Over You searched for: Author "Feiterna-Sperling C" Remove constraint Author: "Feiterna-Sperling C"
128 results on '"Feiterna-Sperling C"'

Search Results

1. Diagnostik und Therapie der Syphilis: Aktualisierung der S2k-Leitlinie 2020 der Deutsche STI-Gesellschaft (DSTIG) in Kooperation mit folgenden Fachgesellschaften: DAIG, dagnä, DDG, DGA, DGGG, DGHM, DGI, DGN, DGPI, DGU, RKI

2. Guidelines and practice of breastfeeding in women living with HIV—Results from the European INSURE survey.

3. Erratum zu: Diagnostik und Therapie der Syphilis. Aktualisierung der S2k-Leitlinie 2020 der Deutsche STI-Gesellschaft (DSTIG) in Kooperation mit folgenden Fachgesellschaften: DAIG, dagnä, DDG, DGA, DGGG, DGHM, DGI, DGN, DGPI, DGU, RKI

4. Prevalence and Clinical Outcomes of Poor Immune Response Despite Virologically Suppressive Antiretroviral Therapy Among Children and Adolescents With Human Immunodeficiency Virus in Europe and Thailand: Cohort Study

6. HIV-Infektion und AIDS

10. Safety, Efficacy, and Pharmacokinetic Analysis of Glecaprevir/Pibrentasvir in Pediatric Patients With Genotypes 1–6 Chronic Hepatitis C Virus (HCV) Infection: Part 2 of the DORA Study

11. Time to Switch to Second-line Antiretroviral Therapy in Children With Human Immunodeficiency Virus in Europe and Thailand

13. Erratum zu: Tuberkulosescreening bei asylsuchenden Kindern und Jugendlichen ≺ 15 Jahren in Deutschland: Stellungnahme der Arbeitsgruppe AWMF-Leitlinie Tuberkulose im Kindes- und Jugendalter: Diagnostik, Prävention und Therapie unter Federführung der Deutschen Gesellschaft für Pädiatrische Infektiologie

14. HIV-Infektionen

16. HIV-Infektionen

19. Consensus-Based Guidelines for Diagnosis, Prevention and Treatment of Tuberculosis in Children and Adolescents

20. S2k-Leitlinie zur Diagnostik, Prävention und Therapie der Tuberkulose im Kindes- und Jugendalter

21. Lamivudine/abacavir maintains virological superiority over zidovudine/lamivudine and zidovudine/abacavir beyond 5 years in children

23. Using CD4 percentage and age to optimize pediatric antiretroviral therapy initiation

24. Chirurgische Behandlung von Kindern mit zervikaler atypischer Mykobakteriose

25. The mother-to-child HIV transmission epidemic in Europe: evolving in the East and established in the West

27. Inter-laboratory comparison of HCV-RNA assay results: Implications for multi-centre research

28. High seroprevalence of human herpes virus 8 (HHV-8) antibodies among vertically HIV-infected pediatric patients living in Germany

33. Autorenverzeichnis

38. A significan sex—but not elective cesarean section—effect on mother-to-child transmission of hepatitis C virus infection

39. The mother-to-child HIV transmission epidemic in Europe: evolving in the East and established in the West

40. Treatment and monitoring of children with chronic hepatitis C in the Pre-DAA era: A European survey of 38 paediatric specialists

41. Comparison of dual nucleoside-analogue reverse-transcriptase inhibitor regimens with HIV-1 who have not previously been treated: the PENTA 5 randomized trial

42. Efficacy and safety of 2-drug regime dolutegravir/lamivudine in pregnancy and breastfeeding - clinical implications and perspectives.

43. Prenatal ultrasound screening and pregnancy outcomes in HIV-positive women in Germany: results from a retrospective single-center study at the Charité-Universitätsmedizin Berlin.

44. Tuberculosis Disease in Immunocompromised Children and Adolescents: A Pediatric Tuberculosis Network European Trials Group Multicenter Case-control Study.

45. Treatment of MDR, Pre-XDR, XDR, and Rifampicin-Resistant Tuberculosis or in Case of Intolerance to at Least Rifampicin in Austria, Germany, and Switzerland.

46. [Treatment of MDR, pre-XDR, XDR and rifampicin resistant tuberculosis or in case of intolerance to at least rifampicin in Austria, Germany and Switzerland - Amendment dated 19.09.2023 to the Sk2-Guideline: Tuberculosis in adulthood of the German Central Committee against Tuberculosis (DZK) on behalf of the German Respiratory Society (DGP)].

47. Performance of QuantiFERON-TB Gold Plus assays in paediatric tuberculosis: a multicentre PTBNET study.

49. [Tuberculosis-Update 2022].

50. [Tuberculosis in adulthood - The Sk2-Guideline of the German Central Committee against Tuberculosis (DZK) and the German Respiratory Society (DGP) for the diagnosis and treatment of adult tuberculosis patients].

Catalog

Books, media, physical & digital resources